These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7452971)

  • 21. Uptake and storage of catecholamines in rabbit brain after chronic reserpine treatment.
    Dahlström A; Fuxe K; Hamberger B; Hökfelt T
    J Pharm Pharmacol; 1967 Jun; 19(6):345-9. PubMed ID: 4382362
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of disulfiram and ascorbic acid on catecholamine content in rat brain.
    Izquierdo JA; Jofré IJ; Acevedo C
    J Pharm Pharmacol; 1972 Apr; 24(4):330-2. PubMed ID: 4402844
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 25. Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats.
    Breese GR; Cooper BR
    Brain Res; 1975 Nov; 98(3):517-27. PubMed ID: 1242372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain monoamines and adrenocortical activation.
    De Schaepdryver A; Preziosi P; Scapagnini U
    Br J Pharmacol; 1969 Mar; 35(3):460-7. PubMed ID: 4309262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Attempted localization of monoamines in human hypothalamus].
    Constantinidis J; Tissot R; De la Torre JC; Geissbuhler F
    Pathol Biol (Paris); 1969 Apr; 17(7):361-3. PubMed ID: 4893904
    [No Abstract]   [Full Text] [Related]  

  • 28. Neonatal antidepressant administration suppresses concurrent active (REM) sleep and increases adult alcohol consumption in rats.
    Hilakivi LA; Hilakivi I; Kiianmaa K
    Alcohol Alcohol Suppl; 1987; 1():339-43. PubMed ID: 2447903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental changes in monoamines of mouse brain.
    Agrawal HC; Glisson SN; Himwich WA
    Int J Neuropharmacol; 1968 Mar; 7(2):97-101. PubMed ID: 5710524
    [No Abstract]   [Full Text] [Related]  

  • 30. Intrastrain difference in serotonin and norepinephrine in discrete areas of rat brain.
    Miller FP; Cox RH; Maickel RP
    Science; 1968 Oct; 162(3852):463-4. PubMed ID: 5683055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy-prone rat.
    Jobe PC; Laird HE; Ko KH; Ray T; Dailey JW
    Epilepsia; 1982 Aug; 23(4):359-66. PubMed ID: 6284498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of imipramine on central monoamine neurons.
    Corrodi H; Fuxe K
    J Pharm Pharmacol; 1968 Mar; 20(3):230-1. PubMed ID: 4385053
    [No Abstract]   [Full Text] [Related]  

  • 33. Apomorphine and monoamines in the brain of rats.
    Benesová O; Benes V
    Act Nerv Super (Praha); 1970; 12(3):238-9. PubMed ID: 5457436
    [No Abstract]   [Full Text] [Related]  

  • 34. A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas.
    Shellenberger MK; Gordon JH
    Anal Biochem; 1971 Feb; 39(2):356-72. PubMed ID: 5555466
    [No Abstract]   [Full Text] [Related]  

  • 35. Receptor binding of corticosterone in monoaminergic structures of the brain of rats after neonatal blockade of the hypophyseoadrenal system.
    Garina IA; Rakitskaya VV; Shalyapina VG
    Neurosci Behav Physiol; 1991; 21(5):387-90. PubMed ID: 1758616
    [No Abstract]   [Full Text] [Related]  

  • 36. Simultaneous quantitation of norepinephrine, dopamine and serotonin in brain during and following chronic naltrexone administration.
    Baron SA; Testa FM; Gintzler AR
    Brain Res; 1985 Aug; 340(1):192-8. PubMed ID: 2862958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of large mesencephalic-diencephalic lesions on the noradrenalin, dopamine and 5-hydroxytryptamine neurons of the central nervous system.
    Andén NE; Fuxe K; Larsson K
    Experientia; 1966 Dec; 22(12):842-3. PubMed ID: 5973236
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of an altered state of the hypophyseo-adrenal system on the concentration of noradrenaline in the brain].
    Rakitskaia VV
    Probl Endokrinol (Mosk); 1973; 19(4):57-60. PubMed ID: 4788101
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological effects of p-chloroamphetamine with respect to current amine hypotheses of affective disorders.
    Dewhurst WG; McKim HR
    Neuropsychobiology; 1980; 6(2):66-71. PubMed ID: 7354908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in brain monoamine levels of rats during cholecystokinin octapeptide-induced suppression of feeding.
    Kádár T; Várszegi M; Sudakov SK; Penke B; Telegdy G
    Pharmacol Biochem Behav; 1984 Sep; 21(3):339-44. PubMed ID: 6093149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.